000			01444nam a2200373Ia 4500
001			265409
003			OCoLC
005			20160527193315.0
008			020409s2002 enka b 001 0 eng
010			_a 2002280285
015			_aGBA2-Y9890
016	7		_a101143391 _2DNLM
020			_a0471496367 (cased)
020			_a0471496375 (pbk.)
040			_aNLM _cNLM _dUKM _dDLC _dUNA _dLVB
042			_anlmcopyc
049			_aPUXA _bev
050	0	0	_aRS403 _b.B57 2002
060	0	0	_a2002 E-505
060	1	0	_aQV 38 _bB632p 2002
082	0	4	_a615.19 _bB6329p _221
100	1		_aBladon, Christine M. _2Local _962826
245	1	0	_aPharmaceutical chemistry _btherapeutic aspects of biomacromolecules _cChristine M. Bladon.
260			_aChichester, West Sussex, England _bWiley & Sons _cc2002.
300			_axii, 221 p. _bill. _c25 cm.
504			_aIncludes bibliographical references and index.
505	0		_aIntroduction -- Endogenous peptides and proteins -- Modification of endogenous peptides and proteins -- The immune system -- Oligonucleotides -- Oligosaccharides -- Appendix.
650	1	2	_aBiopharmaceutics. _2Local _962492
650		6	_aChimie pharmaceutique. _2Local _972824
650		0	_aPharmaceutical chemistry. _2Local _9150474
650	2	2	_aChemistry, Pharmaceutical _2Local _972306
650	2	2	_aBiopolymers _xtherapeutic use. _2Local _962494
856	4	1	_3Table of contents _uhttp://www.loc.gov/catdir/toc/wiley022/2002280285.html
999			_c191325 _d191325